// Simba UK sales rise 295% as mattress sales skyrocketed during lockdown
// It is on track to deliver its best second quarter results to date
// In March, Simba expanded its strategic partnership in the UK and Europe with USleep
Simba has recorded its highest-ever first quarter sales and profits after consumers continued to invest heavily in their sleep during the Covid-19 pandemic.
Sales rose by a colossal 295 per cent year on year in the UK, while global sales skyrocketed 265 per cent over the period.
Simba said performance through the lifting of lockdown has remained strong, and it is on track to deliver its best second quarter results to date.
In March, Simba expanded its strategic partnership in the UK and Europe with USleep, the Belfield Group’s mattress division, which lends Simba additional supply-side stability in the face of all-time high demand and growth.
“Like many firms, we were hesitant about how Brexit would play out, but we made a number of improvements to our supply chain in 2020 which facilitated a smooth transition, rather than putting on the brakes,” Simba chief executive Steve Reid said.
“The shift to online shopping for many consumers that Covid accelerated is also showing no signs of abating, and the overwhelmingly positive reception to the Luxe mattress further confirms quality is a greater purchase driver than price, suggesting that good sleep and a quality mattress is not something to make concessions on.
“Moreover, the growth of the UK business has also spurred solid international growth, and we look forward to accelerating our position and market share in France, China and Canada this year.”
Simba chief operating officer Nicholas Pink said: “Simba’s success has been driven by a formula of consistently evaluating and sharpening up business practices, genuine product innovation and delivering quality.
“Sustained sales growth throughout 2020 has crucially been underpinned with continued and record profitability in 2021, validating that the model is not only robust, but sustainable.”